Company Monitoring Page for Eli-Lilly

latest headlines for company on cafepharma

The Pharmaceutical Industry's 10 Biggest R&D Budgets
Motley Fool
Mon, 09/23/13 - 12:02 pm
Tags:
R&D, Roche, Pfizer, Merck, JNJ, Novartis, Sanofi, GSK, Eli Lilly, AstraZeneca, Bristol-Myers Squibb
3 Drugmakers Developing Revolutionary Psoriasis Treatments
Motley Fool
Sun, 09/22/13 - 11:20 am
Tags:
Celgene, Novartis, Eli Lilly
Eli Lilly And Merck: A Pipeline Of Success?
Seeking Alpha
Mon, 09/16/13 - 05:26 pm
Tags:
Eli Lilly, Merck, Forest Labs
Celgene: FDA Approvals Shining The Biopharma Stock
Seeking Alpha
Mon, 09/16/13 - 11:48 am
Tags:
Celgene, FDA, Bristol-Myers Squibb, AbbVie, JNJ, Eli Lilly, Revlimid, Abraxane
Lilly files $500 million lawsuit against Canada
Fierce Pharma
Fri, 09/13/13 - 09:18 am
Tags:
Canada, Eli Lilly, patents
Novo Nordisk Pushes Ahead In Challenging Year
Investors.com
Tue, 09/10/13 - 04:48 pm
Tags:
Novo Nordisk, Sanofi, Bristol-Myers Squibb, diabetes, Eli Lilly, MannKind
[video]Can This Troubled Pharma Giant Bounce Back?
Motley Fool
Fri, 09/6/13 - 11:00 am
Tags:
Eli Lilly, patent cliff
Merck Hopes Alzheimer's Drug Fares Better Than Competitors
TheStreet.com
Thu, 09/5/13 - 08:50 am
Tags:
Merck, Alzheimer's disease, Pfizer, Eli Lilly, JNJ, bapineuzumab, solanezumab, BACE inhibitors, MK-8931
Patent ruling on Lilly's Alimta lung-cancer drug expected in 2014
Reuters
Wed, 09/4/13 - 05:37 pm
Tags:
Eli Lilly, Alimta, lung cancer, patents
Pretreatment with Effient Found Not Beneficial
Forbes
Tue, 09/3/13 - 09:31 am
Tags:
Effient, Eli Lilly, non-ST-segment-elevation acute myocardial infarction, NSTEMI
Expectations For Eli Lilly's Lung Cancer Drug Rise, But Revenue Concerns Continue
Seeking Alpha
Sat, 08/31/13 - 11:20 am
Tags:
Eli Lilly, necitumumab, lung cancer
Humana and Eli Lilly form research collaboration
Yahoo/Fly on the Wall
Thu, 08/29/13 - 10:17 am
Tags:
R&D, Human, Eli Lilly
Zealand Pharma, Eli Lilly sign obesity, diabetes research deal
Reuters
Thu, 08/29/13 - 09:31 am
Tags:
Eli Lilly, Zealand Pharma, obesity, diabetes, R&D
Understanding the Massive Market Potential of Monoclonal Antibodies
Motley Fool
Wed, 08/28/13 - 04:53 pm
Tags:
monoclonal antibodies, Roche, Herceptin, Rituxan, Avastin, GSK, Amgen, Eli Lilly, Bristol-Myers Squibb, Seattle Genetics, Adcetris, Kadcyla, bapineuzumab, Elan, JNJ, Pfizer, necitumumab, AbbVie, Humira
A Closer Look at the Controversial Market Growth of ADHD Treatments
Motley Fool
Wed, 08/28/13 - 04:49 pm
Tags:
ADHD, Shire, Adderall, Strattera, Eli Lilly, JNJ, Novartis, Concerta, Ritalin
Eli Lilly Might Have A Blockbuster Cancer Drug
Seeking Alpha
Tue, 08/27/13 - 10:54 am
Tags:
Eli Lilly, non-small cell lung cancer, necitumumab
Halt in Zilmax sales fuels demand for rival cattle feed product
Reuters
Mon, 08/26/13 - 09:28 am
Tags:
Zilmax, Merck, Eli Lilly, animal health, Optaflexx
China Biotech In Review: Eli Lilly Joins The Big Pharmas Accused Of Bribing In China
Seeking Alpha
Sun, 08/25/13 - 11:33 am
Tags:
Zhejiang Beta Pharma, BeiGene, Eli Lilly
ChinaGate: Former Lilly Manager Says Docs Were Paid $5 Million
Pharmalot
Fri, 08/23/13 - 09:34 am
Tags:
physician payments, China, Eli Lilly
The Past, Present, and Future of Alzheimer’s Treatments
Motley Fool
Fri, 08/23/13 - 09:26 am
Tags:
Alzheimer's disease, Aricept, Pfizer, Eisai, Actavis, Namenda, Eli Lilly, Forest Labs, bapineuzumab, JNJ, Elan, Perrigo Company, solanezumab, PBT2, Prana Biotechnology

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.